Immunotherapy for the Treatment of Breast Cancer: Emerging New Data
Lida A Mina,1 Shannon Lim,2 Shakeela W Bahadur,1 Abdul T Firoz3 1Hematology Oncology Department, Banner MD Anderson Cancer Center, Gilbert, AZ, USA; 2Pharmacy Department, Banner MD Anderson Cancer Center, Gilbert, AZ, USA; 3Science Department, Arizona State University, Tempe, AZ, USACorrespondence:...
Guardado en:
Autores principales: | Mina LA, Lim S, Bahadur SW, Firoz AT |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f81b79e0b475402abd9d4701e7b12d30 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Opportunities for metastatic triple negative breast cancer therapy
por: Inna P. Ganshina, et al.
Publicado: (2021) -
Editorial: Immunotherapy as an Evolving Approach for the Treatment of Breast Cancer
por: Mai F. Tolba, et al.
Publicado: (2021) -
Immunotherapy for HER2-positive breast cancer: recent advances and combination therapeutic approaches
por: Ayoub NM, et al.
Publicado: (2019) -
The phenomenon of pseudoprogression in cancer immunotherapy: is everything so unambiguous?
por: Vladislav O. Sarzhevskiy, et al.
Publicado: (2021) -
Cure the Incurable? Recent Breakthroughs in Immune Checkpoint Blockade for Hepatocellular Carcinoma
por: Pei-Yi Chu, et al.
Publicado: (2021)